Eliminate the risks of animal-derived components and elevate your bioprocessing with our Recombinant Human Albumin (rHA). Expressed in a highly controlled yeast system (Pichia pastoris), our rHA provides a chemically defined, 100% animal-origin-free (AOF) alternative to human serum albumin (HSA). 

Why Switch from Plasma-Derived HSA to Recombinant? 

While traditional Human Serum Albumin (HSA) has been the industry standard for decades, it brings inherent risks of viral contamination, batch-to-batch inconsistency, and a fluctuating global supply. 

Our Recombinant Human Albumin—expressed in a highly controlled yeast system—solves these challenges: 

• Total Viral Safety: 100% Animal-Origin Free (AOF), eliminating the risk of BSE, TSE, and human blood-borne pathogens (HIV, Hepatitis). 

• Defined Consistency: Recombinant production ensures a single, stable molecular profile every time. No more re-optimizing your media for every new lot. 

• High Monomer Content: Optimized for superior stability and reduced aggregation, ensuring longer shelf life for your biologics.